Harsh R. Shah,
DO
Languages Spoken: English
Languages Spoken: English, Hindi, Gujarati
Harsh Shah DO is an Assistant Professor of Medicine in the Division of Hematology at the Huntsman Cancer Center, University of Utah.
Dr. Shah’s clinical expertise is in treatment of various lymphomas, such as Hodgkin’s Lymphoma, T-cell Lymphomas, DLBCL, Mantle Cell Lymphoma, Follicular Lymphoma, CLL, etc. He has a research interest in immunotherapy resistance pathways in treatment of Hodgkin Lymphomas, particularly the role of Tumor Associated Macrophages. He is also interested in outcomes research and novel educational strategies for medical students, residents, and fellows.
He completed his internal medicine training at Indiana University in Indianapolis and hematology and oncology fellowship at Karmanos Cancer Institute/Wayne State University in Detroit, Michigan. He is certified in both hematology and oncology.
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Assistant Professor (Clinical) |
| Academic Divisions | Hematology/BMT |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.7/ 5
Care provider's explanation of condition/problem
4.7/ 5
Care provider's effort to include me in decisions
4.7/ 5
Wait time at clinic
4.4/ 5
Care provider's concern for questions & worries
4.7/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
March 01, 2022
HUNTSMAN CANCER CENTER
I was impressed by the time and care I received.
UofU Patient
December 06, 2021
HUNTSMAN CANCER CENTER
Dr Shah is thoroughly familiar with the process and subject matter. Explained everything in great detail, listened with utmost care, taking copious notes. My wife and I feel we are in the most capable hands.
UofU Patient
November 22, 2021
HUNTSMAN CANCER CENTER
The N/P wes very thorough in explaining my diagnosis, and ensuring discussion, she was great
UofU Patient
November 21, 2021
HUNTSMAN CANCER CENTER
The physician was very helpful and took the time to first explain and then offer information and answered all my questions. He helped my to be able to ask questions.
UofU Patient
November 16, 2021
HUNTSMAN CANCER CENTER
Good
UofU Patient
November 02, 2021
HUNTSMAN CANCER CENTER
It shows when people like working at any place, and I've noticed that doctors, nurses and staff in general like working at Huntsman. Always a high degree of professionalism, from the doctors to the cafeteria staff. Dr Shah is always very kind and feels like he knows what he's doing. Highly skilled doctor. All his PAs are always very kind and thoughtful. Always a good experience.
UofU Patient
September 10, 2021
HUNTSMAN CANCER CENTER
I am kept informed of my health
UofU Patient
September 06, 2021
HUNTSMAN CANCER CENTER
We really like Dr Shah. Thanks!
UofU Patient
September 03, 2021
HUNTSMAN CANCER CENTER
Awesome Doctors. Love my Doctors here and study coordinator. Everyone is excellent at their job
UofU Patient
August 27, 2021
HUNTSMAN CANCER CENTER
So far I have been pleased with all aspects of my treatment
UofU Patient
August 08, 2021
HUNTSMAN CANCER CENTER
Dr. Shah is great. His care and concern are exemplary.
UofU Patient
August 06, 2021
HUNTSMAN CANCER CENTER
Dr. Shah has settled in and was awesome during my recent appointment. I was spoiled by Dr. Glen and was expecting a smoother transition.
UofU Patient
July 30, 2021
HUNTSMAN CANCER CENTER
Both Dr. Shah and the PA were very responsive to my questions and concerns. I left feeling very good about the plans we made moving forward.
UofU Patient
July 24, 2021
HUNTSMAN CANCER CENTER
Very satisfied so far
UofU Patient
July 20, 2021
HUNTSMAN CANCER CENTER
My doctor was awesome
UofU Patient
June 27, 2021
HUNTSMAN CANCER CENTER
The ratings in this section would have all been very good if I had taken it upon myself to ask more questions
UofU Patient
June 19, 2021
HUNTSMAN CANCER CENTER
good
UofU Patient
June 18, 2021
HUNTSMAN CANCER CENTER
I was giving bad news on blood test results will no directional guidance where to go next.
UofU Patient
June 14, 2021
HUNTSMAN CANCER CENTER
After Dr. Martha Glen's retirement, I was concerned about her replacement. Dr. Shah was exceptionally through and helpful. No one can replace Dr. Glen's "bedside" manner, but Dr. Shah was a pleasant surprise.
UofU Patient
May 23, 2021
HUNTSMAN CANCER CENTER
Jessica Coon is amazing, always.Great to meet Dr. Shah. very impressive.
UofU Patient
May 08, 2021
HUNTSMAN CANCER CENTER
She was wonderful!!
UofU Patient
May 07, 2021
HUNTSMAN CANCER CENTER
Explained pros and cons of doing a biopsy of two apparent enlarged lymph nodes.
UofU Patient
May 07, 2021
HUNTSMAN CANCER CENTER
Dr. Shah is the best. The staff he has assembled are also great.
Languages Spoken: English, Hindi, Gujarati
Harsh Shah DO is an Assistant Professor of Medicine in the Division of Hematology at the Huntsman Cancer Center, University of Utah.
Dr. Shah’s clinical expertise is in treatment of various lymphomas, such as Hodgkin’s Lymphoma, T-cell Lymphomas, DLBCL, Mantle Cell Lymphoma, Follicular Lymphoma, CLL, etc. He has a research interest in immunotherapy resistance pathways in treatment of Hodgkin Lymphomas, particularly the role of Tumor Associated Macrophages. He is also interested in outcomes research and novel educational strategies for medical students, residents, and fellows.
He completed his internal medicine training at Indiana University in Indianapolis and hematology and oncology fellowship at Karmanos Cancer Institute/Wayne State University in Detroit, Michigan. He is certified in both hematology and oncology.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Internal Medicine
-
Assistant Professor (Clinical) |
| Academic Divisions | Hematology/BMT |
Education History
| Fellowship | Karmanos Cancer Institute-Wayne State University Hematology-Oncology Fellow, 2019 |
| Residency | Indiana University School of Medicine Internal Medicine Resident, 2016 |
| Professional Medical | Kirksville College of Osteopathic Medicine, AT Still University of Health Sciences Osteopathic Medicine D.O., 2013 |
| Graduate Training | University of Michigan Biomedical Engineering M.S.E., 2009 |
| Undergraduate | University of Michigan Biomedical Engineering B.S.E., 2008 |
Selected Publications - Journal Articles
Journal Article
- Harsh Shah, Seongho Kim, Scott Klimecki, Karl Charlson, Joseph Uberti, Charles A Schiffer, Mark A Fiala Erlene Seymour (2022). Racial disparities in time to hematopoietic cell transplant among patient with hematologic malignancies at a large urban academic center. Bone Marrow Transplantation. Supplement.
- Shah HR, Stephens DM (2021). Is there a role for anti-CD20 antibodies in CLL? Hematology Am Soc Hematol Educ Program, 2021(1), 68-75.
- Harsh Shah, Hyejeong Jang, Paramveer Singh, Jorgena Kosti, Andrew Kin, Asif Alavi, Voravit Ratanatharathorn, Lois Ayash, Joseph Uberti, Radhakrishnan Ramchandren, Seongho Kim, Abhinav Deol (11/15/2021). Improved post-ASCT survival of relapsed/refractory classical Hodgkin lymphoma patients in the era of novel agents.
- Isabella Frances McNamara, Scott Rizzi, Bryan Still, Harsh Shah (2021). An unusual cause of encephalopathy in the setting of a new diagnosis of DLBCL. 7.
- Orellana-Noia VM, Reed D, McCook AA, Sen JM, Barlow CM, Malecek MK, Watkins MP, Kahl BS, Spinner MA, Advani R, Voorhees TJ, Snow A, Grover NS, Ayers AA, Romancik J, Liu Y, Huntington SF, Chavez JC, Saeed H, Lazaryan A, Raghunathan V, Spurgeon SE, Ollila TA, Del Prete C, Olszewski A, Ayers EC, Landsburg DJ, Echalier B, Lee J, Kamdar M, Caimi PF, Fu T, Liu J, David KA, Alharthy H, Law JY, Karmali R, Shah HR, Stephens DM, Major A, Rojek AE, Smith SM, Yellala A, Kallam A, Nakhoda S, Khan N, Sohail MA, Hill BT, Barrett-Campbell O, Lansigan F, Switchenko JM, Cohen JB, Portell CA (2021). Single-route CNS prophylaxis for aggressive non-Hodgkin lymphomas: real-world outcomes from 21 US academic institutions. Blood, 139, 413-423.
- Shah HR, Stephens DM, Seymout J, Maddocks K (2021). Incorporating Novel Targeted and Immunotherapeutic Agents in the Treatment of B-Cell Lymphomas. Am Soc Clin Oncol Educ Book, 41, 310-327.
- Harsh Shah, Deborah Stephens, John Seymour, Kami Maddocks (03/25/2021). Incorporating Novel Targeted and Immunotherapeutic Agents in Treatment of B-Cell Lymphomas.
- Vaishampayan U, Shah HR, Asad MF, Shi D, Brenda D, Stacey S, Jason D, Cher ML, Samantray J, Aoun HD (2020). Adrenal Metastases as Sanctuary Sites in Advanced Renal Cancer. 7(4).
- Shah HR, Kim S, Singh P, Alavi A, Ratanatharathom V, Ayash L, Uberti J, Deol A (2019). Clinical outcomes of multiple myeloma patients who undergo autologous hematopoietic stem cell transplant with G-CSF or G-CSF and plerixafor mobilizes grafts. Am J Hematol.
- Shah H, Vaishampayan U (2018). Therapy of Advanced Prostate Cancer: Targeting the Androgen Receptor Axis in Earlier Lines of Treatment. Target Oncol, 13(6), 679-689.
- Shah H, Bradford C, Sayar H (2015). Acute Promyelocytic Leukemia Presenting with Severe Marrow Fibrosis. Case Rep Hematol, 2015, 826894.
Case Report
Abstract
- Shah H, et al (2015). Quality of Life Survey in Nonmyeloablative Bone Marrow Transplant Patients at a Large Academic Center [Abstract]. Blood, 126(56), 12.